Sutro Biopharma STRO Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Sutro Biopharma in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sutro Biopharma's increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sutro Biopharma's increase (decrease) in prepaid expense and other assets?
- Sutro Biopharma (STRO) reported increase (decrease) in prepaid expense and other assets of $1M in Q1 2026.
- How has Sutro Biopharma's increase (decrease) in prepaid expense and other assets changed year-over-year?
- Sutro Biopharma's increase (decrease) in prepaid expense and other assets increased by 9218.2% year-over-year, from -$11K to $1M.
- What is the long-term trend for Sutro Biopharma's increase (decrease) in prepaid expense and other assets?
- Over 2 years (2022 to 2025), Sutro Biopharma's increase (decrease) in prepaid expense and other assets has grown at a 133.7% compound annual growth rate (CAGR), from $3.54M to -$19.35M.
- What does increase (decrease) in prepaid expense and other assets mean?
- This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.